Yarbrough Capital’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Yarbrough Capital’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-31,160	Closed	-$5.03M	–	163
2025 Q2	$5.03M	Hold	31,160	–	–	0.18%	51
2025 Q1	$5.3M	Hold	31,160	–	–	0.23%	45
2024 Q4	$5.18M	Hold	31,160	–	–	0.2%	47
2024 Q3	$5.36M	Hold	31,160	–	–	0.22%	45
2024 Q2	$4.8M	Hold	31,160	–	–	0.2%	48
2024 Q1	$4.79M	Hold	31,160	–	–	0.21%	51
2023 Q4	$4.92M	Hold	31,160	–	–	0.26%	46
2023 Q3	$4.56M	Hold	31,160	–	–	0.27%	50
2023 Q2	$4.77M	Hold	31,160	–	–	0.27%	49
2023 Q1	$4.83M	Hold	31,160	–	–	0.39%	45
2022 Q4	$4.8M	Hold	31,160	–	–	0.38%	43
2022 Q3	$4.11M	Hold	31,160	–	–	0.33%	50
2022 Q2	$4.22M	Hold	31,160	–	–	0.32%	47
2022 Q1	$4.65M	Hold	31,160	–	–	0.26%	52
2021 Q4	$5.05M	Buy	+31,160	New	+$5.04M	0.27%	51

Other funds holding FBT

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Yarbrough Capital's FBT Position: Q3 2025 in Review

Yarbrough Capital sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2025, closing a stake of 31,160 shares — an estimated $5.03M sold.

Yarbrough Capital first reported a position in FBT in Q4 2021 and held it in 15 quarters. The position peaked at $5.36M in Q3 2024. 253 funds tracked by Wall St. Rank hold FBT as of Q3 2025.

Yarbrough Capital reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2025 after selling out during the quarter.
Yarbrough Capital sold 31,160 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2025, an estimated $5.03M.
Yarbrough Capital first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2021 and held it in 15 quarters.
Yarbrough Capital's First Trust NYSE Arca Biotechnology Index Fund position peaked at $5.36M in Q3 2024.
253 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2025.

Based on Yarbrough Capital's 13F filing for Q3 2025, filed 20 Oct 2025.